Two decades of GSK rotavirus vaccine (RV1): a global analysis to estimate vaccination completion and deaths averted in children under 5 years
Background Rotavirus vaccination plays a key role in reducing rotavirus gastroenteritis (RVGE) related deaths. This analysis estimated the number of children under 5 years of age fully vaccinated with GSK rotavirus vaccine (RV1) since launch (2004) and its impact on RVGE-related deaths worldwide.Res...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2025-12-01
|
| Sarja: | Expert Review of Vaccines |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/14760584.2025.2564167 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|